Press Releases
Search
-
18 Dec 2019
bioMérieux and the Fleming Fund: working together to strengthen diagnostic capacity and tackle antimicrobial resistance in low- and middle-income countries
London (UK), Marcy l’Étoile (France) – December 18, 2019 – bioMérieux, a world leader in in vitro diagnostics which develops and manufactures testing solutions (systems, reagents, software, services) ...
-
22 Oct 2019
Third-Quarter 2019 Business Review
Organic growth of 6.8% at constant exchange rates and scope of consolidation over the first nine months of the year: €1,928 million in sales Up 10.3% as reported Acceleration of organic growth in sale...
-
04 Sep 2019
First-Half 2019 Results
bioMérieux – First-Half 2019 Results Organic sales growth of 5.5% for first-half 2019: €1,275 million in sales Up 9.1% as reported As expected, growth accelerated in the second quarter, up to 7.4% at ...
-
26 Jun 2019
bioMérieux et l’État de Côte d’Ivoire inaugurent le Centre de formation bioMérieux et signent un accord de collaboration
L’État de Côte d’Ivoire et bioMérieux, acteur mondial du diagnostic in vitro, annoncent la signature d’un mémorandum d’accord de collaboration à l’occasion de l’inauguration du Centre de formation de ...
-
06 Jun 2019
bioMérieux increases its holding in Hybiome from 54% to 67%
bioMérieux, a world leader in the field of in vitro diagnostics, today announced an increase of its shareholding in Suzhou Hybiome Biomedical Engineering Co. Ltd. This announcement follows the earlier...
-
13 May 2019
NEPHROCHECK Biomarkers TIMP-2 and IGFBP7 Included in the ERAS “Guidelines for Perioperative Care in Cardiac Surgery”
The NEPHROCHECK® Test biomarkers (TIMP-2 and IGFBP7) that indicate kidney stress in advance of acute kidney injury (AKI) have been included in the “Guidelines for Perioperative Care in Cardiac Surgery...